21 January 2018
News and Views
Links and Services
Patients with moderate to severe ulcerative colitis treated with infliximab are less likely to undergo colectomy, finds a study in the October issue of Gastroenterology.
The efficacy of infliximab for treating patients with ulcerative colitis has been established.
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors